Atlas FDA

CARPENTIER-EDWARDS BIOPROSTHETIC VALVED CONDUIT

FDA premarket approval P870056/S006 · decided 1998-08-07

Approval details

PMA number
P870056
Supplement
S006
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
CARPENTIER-EDWARDS BIOPROSTHETIC VALVED CONDUIT
Generic name
replacement Heart-valve
Applicant
Edwards Lifesciences, LLC
Date received
1998-02-25
Decision date
1998-08-07
Days to decision
163 days
Decision code
APPR
Product code
DYE
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval for adding the Model 4300 valved conduit and is indicated for correction of pulmonary stenosis or atresia and complex congenital malformations requiring Rastelli-type operations, and for correction of tricuspid atresia.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02